M Ventures β Full Portfolio
117 tracked investments Β· listed companies and verified rows first
Xilio (Xilio Therapeutics) is a clinical-stage biotechnology company developing tumor-selective immunotherapies, including checkpoint inhibitors, T cell engagers and related molecules, for the treatment of cancer.
BiotechHealthtechWaltham, US
Paul Clancy(Director)Daniel Curran(Director)Nancy Hong(Director)Rachel Humphrey(Director)Daniel Lynch(Director)Michael Ross(Director)
Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech.
BiotechDeep TechMedical DevicesCulver City, US
Leroy Hood(Director)Andreas Jurgeit(Director)James Heath(Director)Heather Agnew(Executive Officer)Albert Luderer(Executive Officer, Director)Douglas Fisher(Director)
Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)Jiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)Robert Carson(Executive Officer, Director)Terry Lo(Director)Seth Benson(Executive Officer)Simona Levi(Executive Officer)
BioSpace is a platform providing news, job listings, and recruitment marketing solutions for the life sciences industry.
BiotechHealthtechHR TechMarketing TechMedia & EntertainmentMedical DevicesSaaSDes Moines, US
Josh Goodwin(CEO)
Radiopharmaceutical company developing targeted cancer therapies using alpha-particle emitting radionuclides.
Developing The Benchtop Cell Factory, an end-to-end platform for Cell and Gene Therapy manufacturing using microfluidic technology.
The page describes Photonic Fabric, an optical interconnect technology platform for the scale-up interconnect market that enables high-bandwidth, power-efficient links for AI data center infrastructure.
AI & Machine LearningDeep TechSector AgnosticSemiconductorsSanta Clara, US
Preetinder Virk(Chief Operating Officer)David Lazovsky(President and Chief Executive Officer)Kelyn Brannon(Chief Financial Officer)Philip Winterbottom(Chief Technology Officer)Alexis Bjorlin(Director)
BoardLip-Bu Tan(Director)
ChEmpower develops an abrasive-free, environmentally sustainable chemical-mechanical planarization (CMP) process and consumables such as polishing pads for semiconductor fabrication, aiming to increase chip yields, simplify fab processes, and recycle water and recover metals.
CleantechNew MaterialsSemiconductorsBeaverton, US
SUDHANSHU MISRA(Executive Officer, Director)Sudhanshu Misra(CEO)SV Babu(CTO)
BoardSCOTT SHAW(Director)OWEN LOZMAN(Director)JESSICA FREYER(Director)
Concerto develops microbial ecology data and AI tools to engineer microbe-based products for consumer health applications including skincare, chronic disease, and nutrition.
AI & Machine LearningBiotechDeep TechCambridge, US
Vera Schroeder(Director)Jared Kehe(Executive Officer, Director)Cheri Ackerman(Executive Officer, Director)Bernardo Cervantes(Executive Officer, Director)
BoardSarah Luppino(Director)
Disco Pharmaceuticals develops cancer therapies using a cell surfaceome discovery technology to identify new molecular targets.
BiotechHealthtech
Electroninks develops metal complex conductive inks for semiconductor packaging, printed circuit boards, consumer electronics, and wearables that achieve conductivities up to 90% of bulk metal at low annealing temperatures.
Advanced ManufacturingNew MaterialsSemiconductorsAustin, US
IKAS builds AI and modeling-based industrial intelligent manufacturing solutions for companies across the semiconductor supply chain (chip design, wafer fabrication, packaging and testing, equipment, and materials) as well as the power and energy sector.
Advanced ManufacturingAI & Machine LearningSemiconductorsBeijing, CN
ImmuneBridge is a company working in cell-based cancer immunotherapy, including research on engineered natural killer cells for solid tumor treatment.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Alicia Jackson(Director)Stuart Alexander Jacobson(Executive Officer, Director)Gregory A. Bonfiglio(Director)Peretz Partensky(Executive Officer, Director)Mary Kim Warren(Director)Nina Horowitz(Chief Executive Officer)
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.
BiotechDigital HealthMedical DevicesWaltham, US
Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)Juergen Eckhardt(Director)
BoardLaura Brass(Director)
iOmx is a clinical-stage biotech company developing targeted cancer immunotherapies for common solid tumor indications, translating tumor immune evasion biology into biomarker-enabled drug programs.
BiotechHealthtech
iOnctura is a clinical-stage drug development company developing precision oral small-molecule therapies targeting the tumor-stroma-immune interface, with a pipeline including roginolisib and cambritaxestat in cancers such as uveal melanoma and pancreatic cancer.
BiotechDeep TechHealthtechMedical Devices
Catherine Pickering(Co-Founder & CEO)Lars van der Veen(Co-Founder & CSO)Michael Lahn(CMO)Elizabeth Holt(CBO)Steven Sciuto(CFO)Michelle Tsai(COO)
IonKraft, a spin-off from the Institute of Plastics Processing (IKV) at RWTH Aachen University, develops a barrier coating technology for mono-material plastic containers that provides the barrier and chemical resistance of multi-layer packaging while remaining fully recyclable.
Advanced ManufacturingCircular EconomyCleantechNew MaterialsAachen, DE
Bene(Co-Founder & Managing Director)Monty(Co-Founder & Managing Director)
BiotechLondon
Harrison Rickerby(Executive Officer, Director)
BoardJames Field(Executive Officer, Director)
LabGenius develops EVA, an automated antibody discovery platform that uses machine learning and automation to identify and co-optimize complex therapeutic antibodies such as multispecifics.
AI & Machine LearningBiotechDeep Tech
New York, US
Nena Golubovic(Director)Vincent Lee(Executive Officer, Director)Ioannis Kymissis(Executive Officer, Director)Mark Halfman(Director)
BoardMichael Burychka(Director)
Metalenz develops metasurface optics technology for optical sensing in consumer and industrial devices.
Deep TechHardwareSemiconductorsStoneham, US
Robert Charles Devlin(Executive Officer, Director)Federico Capasso(Director)
BoardXuhui Shao(Director)
Neurable develops brain-computer interface (BCI) technology via smart headphones designed to enhance employee focus, productivity, and well-being in corporate settings.
AI & Machine LearningDeep TechHardwareHealthtechHR TechAnn Arbor, US
Dr. Ramses Alcaide(CEO and Co-Founder)Michael Thompson(Executive Officer)Adam Eizenberg-Molnar(Cofounder)
Nanostructured copper thermal interface materials for enhanced chip heat transfer
Pittsburgh, US
Sheng Shen(Executive Officer, Director)Robert Wenner(Executive Officer)
BoardTina Tosukhowong(Director)Eric Rosenblum(Director)Ning Li(Executive Officer, Director)Paul Sheng(Director)
Nucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets.
AI & Machine LearningBiotechDeep Tech
PxE develops holographic imaging technology that captures fused RGB, infrared, and depth data from a single snapshot using one lens, sensor, and chip.
Deep TechHardwareSemiconductors
Platform technology to identify therapeutics that selectively target the protein degradation pathway.
South Pasadena, US
Jonathan Seamus Blackley(Executive Officer, Director)Gregory Papadopoulos(Director)
A tech startup operating in stealth mode on an undisclosed vision; it has developed Veluminum, a matte, velvet-like coating for aluminum.
Deep TechHardwareNew Materials
BiotechLos Angeles, US
Aydogan Ozcan(Director, Promoter)Yair Rivenson(Executive Officer, Director, Promoter)Bauke Anninga(Director)
BoardRobert Crutchfield(Director)Scott Barclay(Director)Gilbert Hakim(Director)
Plexium is a targeted protein degradation company developing small molecule therapeutics for treating diseases with high unmet medical needs using their proprietary DELTA Discovery platform.
AI & Machine LearningBiotechDeep TechSan Diego, US
Michael Martin, Ph.D.(Chief Executive Officer, President)Jorge F. DiMartinoMichael Martin(President, Chief Executive Officer)
BoardMike Grey(Executive Chairman)in
Broomfield, US
Jason Sickler(Executive Officer, Director)Cory Pecinovsky(Executive Officer, Director)
BoardDaniel Franke(Director)Adithyaram Narisimha(Director)Bernard Lupien(Director)
Lundbeck is a global pharmaceutical company specializing in researching, developing, manufacturing, and commercializing medications for brain diseases and neurological conditions.
BiotechHealthtechMedical DevicesCopenhagen, DK
Quintessent develops optical connectivity solutions to address chip-to-chip communication bottlenecks in large-scale computing and AI systems.
AI & Machine LearningCloud ComputingDeep TechHardwareSemiconductorsSanta Barbara, US
Alan Liu(CEO, Co-Founder & Board Member)Brian Koch(VP of Engineering & Co-Founder)John Bowers(Chairman of the Board & Co-Founder)
BiotechGreenville, US
Katherine Warner(Executive Officer)Joshua Resnick(Director)Michael Solomon(Director)Kevin Weeks(Executive Officer, Director)John Gustofson(Director)
BoardMike Dial(Director)
SEEQC develops a digital quantum computing System-on-a-Chip that integrates classical readout, control, error correction, and data processing functions with quantum processors to reduce complexity and cost.
Deep TechQuantum ComputingSemiconductorsElmsford, US
Oleg Mukhanov(CSO)John Levy(CEO & Chairman, Co-founder)Raja Bal(CFO)Tim Anglim(Executive Officer)Michael Messener(Director)Matthew Hutchings(Executive Officer)
Sonde provides an API/SDK platform that analyzes vocal biomarkers to detect health signals from voice, offering insights into users' mental, cognitive, and respiratory fitness.
AI & Machine LearningDigital HealthHealthtech
STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.
BiotechHealthtechMedical Devices
SynSense develops neuromorphic intelligence chips and vision systems for human-machine and brain-computer interfaces, optimizing for ultra-low power consumption and latency in edge computing applications.
AI & Machine LearningDeep TechSemiconductors
Dr. Ning Qiao(Founder)Prof. Giacomo Indiveri(Founder)
Theolytics develops oncolytic adenovirus-based immunotherapies to overcome the tumor microenvironment barriers in solid cancers.
BiotechDeep TechMedical Devices
Cohu provides test automation, inspection, and metrology solutions to semiconductor manufacturers to optimize yield and productivity across applications including AI, high-performance computing, automotive, medical devices, and telecommunications.
Advanced ManufacturingDeep TechSemiconductorsSeattle, US
Matthew R McLaughlin(Executive Officer, Director)Jonathan L Herlocker(Executive Officer, Director)
BoardAshmeet Sidana(Director)
Tipe is a headless content management system designed for developers, offering schema-based content modeling and framework integrations for building web applications.
Data & InfrastructureDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US
Scott Moss(Founder/CEO)inMichael Moss(Founder/CPO)inPatrick Stapleton(Founder/CTO)in
RNA therapeutics; NASDAQ TBIO, acquired by Sanofi.
Platform company targeting selective clearance of intracellular protein aggregates in neurodegenerative disease.
UNISERS develops contamination detection tools for semiconductor manufacturers, using a vacuum-based plasma coating technology combined with optical microscopy (SEPS and SERS techniques) to detect and characterize nanoparticle contaminants on silicon wafers.
Advanced ManufacturingDeep TechSemiconductors
Enara Bio is a biopharmaceutical company developing cancer immunotherapies for solid tumors, using its EDAPT platform to discover novel tumor-specific "Dark Antigens" from genomic dark matter and its EnTiCE platform to build bispecific T-cell engagers.
Biotech
.png)
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.